Dierssen M, Ruiz F, Flórez J, Hurlé M A
Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander, Spain.
Eur J Pharmacol. 1991 Jun 6;198(2-3):149-55. doi: 10.1016/0014-2999(91)90614-v.
We analyzed the interaction between sufentanil, a selective mu agonist, and two dihydropyridines, the Ca2+ antagonist, nimodipine, and the Ca2+ agonist, Bay K 8644, on the respiratory actions induced in the brainstem of cats. Drugs were applied topically to the ventral medullary surface. Sufentanil (0.26-26 nmol) consistently induced an immediate and dose-dependent reduction in tidal volume. Respiratory frequency was only depressed by the higher doses of the opiate. Pretreatment with nimodipine (0.19 and 0.38 mumol) potentiated the respiratory depression induced by sufentanil (0.26 nmol). The potentiation included both frequency and tidal volume. On the other hand, under the influence of Bay K 8644 (0.28 nmol), the respiratory effect of the opiate (7.8 nmol) was partially antagonized. Our results indicate that modulation of the L-type Ca2+ channels by dihydropyridines modifies sufentanil-induced respiratory depression at the controlling medullary mechanisms of breathing.
我们分析了选择性μ激动剂舒芬太尼与两种二氢吡啶类药物(钙拮抗剂尼莫地平和钙激动剂Bay K 8644)在猫脑干诱发的呼吸作用上的相互作用。将药物局部应用于延髓腹侧面。舒芬太尼(0.26 - 26纳摩尔)持续引起潮气量立即且剂量依赖性降低。仅较高剂量的阿片类药物会抑制呼吸频率。用尼莫地平(0.19和0.38微摩尔)预处理可增强舒芬太尼(0.26纳摩尔)诱发的呼吸抑制。这种增强包括频率和潮气量。另一方面,在Bay K 8644(0.28纳摩尔)的影响下,阿片类药物(7.8纳摩尔)的呼吸作用被部分拮抗。我们的结果表明,二氢吡啶类药物对L型钙通道的调节在呼吸的控制延髓机制中改变了舒芬太尼诱发的呼吸抑制。